SCHEMBL9348245

SCHEMBL9348245

COc1ccc(-n2c(=O)c(CCCO)c(O)c3cccnc32)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.47
PDE10A Q9Y233 3/20 0.46
MAPT P10636 2/20 0.45
LMNA P02545 1/20 0.45
KAT2B Q92831 1/20 0.44
CYP1A2 P05177 3/20 0.43
CYP3A4 P08684 3/20 0.43
CYP2C9 P11712 3/20 0.43
CYP2C19 P33261 3/20 0.43
KMT2A Q03164 2/20 0.43
CYP2D6 P10635 2/20 0.43
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 5/20 0.42
G6PD P11413 1/20 0.42
TLR8 Q9NR97 1/20 0.42
PTGDR2 Q9Y5Y4 2/20 0.41
RAB9A P51151 2/20 0.41
NPC1 O15118 1/20 0.41
USP2 O75604 2/20 0.40
TSHR P16473 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10667933 0.97 PKM (0.47) PKMPDE10AMAPTLMNAKAT2B
SCHEMBL9352348 0.89 ALDH1A1 (0.47) MAPTKAT2BCYP1A2CYP3A4CYP2C9
SCHEMBL10378879 0.87 SMN1; SMN2 (0.45) MAPTLMNAKAT2BCYP1A2KMT2A
SCHEMBL9352330 0.87 FEN1 (0.51) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL9352380 0.86 ALDH1A1 (0.46) MAPTKAT2BCYP1A2CYP3A4CYP2C9
SCHEMBL9348332 0.86 MAPT (0.45) MAPTKAT2BCYP1A2CYP3A4CYP2C9
SCHEMBL10379176 0.85 PKM (0.46) PKMPDE10AMAPTLMNAKAT2B
SCHEMBL10654723 0.84 ALDH1A1 (0.49) MAPTKAT2BCYP1A2CYP3A4CYP2C9
SCHEMBL9348282 0.83 FEN1 (0.50) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL9348174 0.83 MAPT (0.44) MAPTKAT2BCYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5350755-A Treatment of psoriasis or eczema with naphthyridine derivative SCHERING CORPORATION (US) 1994-09-27 US disclosed
EP-0127135-B1 FUSED TRICYCLIC DERIVATIVES OF NAPHTHYRIDINONE AND PYRIDONE AND THE CORRESPONDING THIONES SCHERING CORPORATION (US) 1990-08-29 EP disclosed
US-4775524-A PSORIASIS SCHERING CORPORATION (US) 1988-10-04 US disclosed
US-4740511-A ANTIALLERGENS, ANTIINFLAMMATORY, ANTIULCER AGENTS SCHERING CORPORATION (US) 1988-04-26 US disclosed
US-4680298-A Tricyclic anti-allergy and use as anti-inflammatory agents SCHERING CORPORATION (US) 1987-07-14 US disclosed
US-4680297-A Tricyclic positive inotropic agents SCHERING CORPORATION (US) 1987-07-14 US disclosed
US-4652564-A Substituted spiro pyridine derivatives as anti-allergy and antiinflammatory agents SCHERING CORPORATION (US) 1987-03-24 US disclosed
US-4632923-A Substituted hetero spiro pyridine derivatives as anti-allergy and anti-inflammatory agents SCHERING CORPORATION (US) 1986-12-30 US disclosed
EP-0127135-A2 Fused tricyclic derivatives of naphthyridinone and pyridone and the corresponding thiones SCHERING CORPORATION (US) 1984-12-05 EP disclosed